News stories about Aetna (NYSE:AET) have been trending somewhat positive on Tuesday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Aetna earned a media sentiment score of 0.20 on Accern’s scale. Accern also assigned media stories about the company an impact score of 45.2589140784287 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

Aetna (AET) traded down 3.08% during mid-day trading on Tuesday, hitting $156.04. The stock had a trading volume of 3,191,307 shares. Aetna has a 1-year low of $104.59 and a 1-year high of $164.52. The firm has a market cap of $51.82 billion, a P/E ratio of 34.64 and a beta of 0.53. The stock has a 50 day moving average of $157.50 and a 200-day moving average of $145.70.

Aetna (NYSE:AET) last posted its quarterly earnings data on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the prior year, the business earned $2.21 EPS. The business’s revenue for the quarter was down 2.7% compared to the same quarter last year. Analysts predict that Aetna will post $9.55 EPS for the current fiscal year.

AET has been the subject of a number of analyst reports. Cowen and Company set a $170.00 price objective on Aetna and gave the company a “buy” rating in a research report on Saturday, May 27th. Argus restated a “buy” rating and set a $165.00 price objective (up previously from $145.00) on shares of Aetna in a research report on Tuesday, May 30th. ValuEngine upgraded Aetna from a “hold” rating to a “buy” rating in a research report on Friday, June 2nd. Morgan Stanley initiated coverage on Aetna in a research report on Tuesday, June 6th. They set an “overweight” rating and a $162.00 price objective for the company. Finally, Royal Bank of Canada boosted their price objective on Aetna from $147.00 to $162.00 and gave the company an “outperform” rating in a research report on Friday, June 9th. Seven analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $159.04.

TRADEMARK VIOLATION WARNING: “Aetna (AET) Receiving Somewhat Positive Media Coverage, Analysis Shows” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at

In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the company’s stock in a transaction on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 1.14% of the stock is currently owned by corporate insiders.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Insider Buying and Selling by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.